Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Rheumatology journal rankings 2023
67 ranked journals · Subfield in Medicine
Rheumatology has 67 ranked journals in 2023. The median journal has an OJR of 0.85, below the world average of 1.00, down 0.02 on 2022; Q1 starts at OJR 1.40. The top three are Arthritis & Rheumatology, Autoimmunity Reviews, and Nature Reviews Rheumatology.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Rheumatology67
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
67 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1Arthritis & RheumatologyWiley · United States | 2.93Q1 | 7.81 1.59 down from 2022 | 874 | 74% | $5,190 | ||
2Autoimmunity ReviewsElsevier BV · Netherlands | 2.65Q1 | 8.08 3.34 down from 2022 | 478 | 48% | $4,730 | ||
3Nature Reviews RheumatologyNature Portfolio · United Kingdom | 2.53Q1 | 9.84 0.51 down from 2022 | 513 | 25% | — | ||
4Current Rheumatology ReportsSpringer Science+Business Media · United States | 2.37Q1 | 7.23 0.91 up from 2022 | 209 | 44% | $4,490 | ||
5Osteoarthritis and CartilageElsevier BV · United Kingdom | 2.32Q1 | 6.03 0.03 up from 2022 | 545 | 99% | $3,700 | ||
6Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 2.30Q1 | 5.27 0.68 down from 2022 | 145 | 42% | $4,180 | ||
7Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 2.03Q1 | 5.12 0.50 down from 2022 | 196 | 29% | — | ||
8RMD OpenOABMJ · United Kingdom | 1.98Q1 | 5.61 1.16 down from 2022 | 528 | 100% | $2,391 | ||
9The Lancet RheumatologyElsevier BV · United Kingdom | 1.96Q1 | 6.36 4.76 down from 2022 | 463 | 49% | $7,280 | ||
10Annals of the Rheumatic DiseasesBMJ · United Kingdom | 1.87Q1 | 7.44 1.07 up from 2022 | 2,087 | 98% | $4,870 | ||
11Arthritis Research & TherapyOABioMed Central · United Kingdom | 1.83Q1 | 4.96 0.38 down from 2022 | 842 | 100% | $3,690 | ||
12Arthritis Care & ResearchWiley · United States | 1.76Q1 | 4.04 0.37 down from 2022 | 734 | 77% | $4,640 | ||
13Journal of Translational AutoimmunityOAElsevier BV · Netherlands | 1.68Q1 | 5.69 0.83 up from 2022 | 145 | 100% | $3,180 | ||
14Seminars in Arthritis and RheumatismElsevier BV · United States | 1.48Q1 | 4.37 0.93 down from 2022 | 539 | 61% | $4,370 | ||
15Therapeutic Advances in Musculoskeletal DiseaseOASAGE Publishing · United Kingdom | 1.47Q1 | 3.98 0.74 down from 2022 | 299 | 100% | $2,650 | ||
16Lupus Science & MedicineOABMJ · United Kingdom | 1.47Q1 | 4.20 0.22 up from 2022 | 222 | 100% | $2,391 | ||
17Rheumatology and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.40Q1 | 3.39 0.87 down from 2022 | 305 | 100% | $7,400 | ||
18Expert Review of Clinical ImmunologyTaylor & Francis · United Kingdom | 1.37Q2 | 4.32 0.55 down from 2022 | 319 | 32% | — | ||
19Lara D. VeekenOxford University Press · United Kingdom | 1.36Q2 | 3.77 0.28 down from 2022 | 2,288 | 78% | $4,597 | ||
20Rheumatology InternationalSpringer Science+Business Media · Germany | 1.30Q2 | 3.92 0.89 down from 2022 | 737 | 44% | $4,990 | ||
21Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.29Q2 | 2.78 0.18 down from 2022 | 152 | 17% | $3,500 | ||
22CartilageSAGE Publishing · United States | 1.23Q2 | 3.04 0.04 up from 2022 | 366 | 100% | $2,650 | ||
23ACR Open RheumatologyOAWiley · United States | 1.15Q2 | 2.80 0.61 down from 2022 | 352 | 100% | $3,550 | ||
24European Cells and MaterialsOASwitzerland | 1.09Q2 | 3.24 0.03 down from 2022 | 137 | 100% | $1,000 | ||
25Clinical RheumatologySpringer Science+Business Media · Belgium | 1.04Q2 | 3.00 0.55 down from 2022 | 1,521 | 36% | $4,890 | ||
26BMC RheumatologyOABioMed Central · United Kingdom | 0.99Q2 | 2.46 0.19 down from 2022 | 219 | 100% | $2,190 | ||
27Open Access Rheumatology Research and ReviewsOADove Medical Press · New Zealand | 0.98Q2 | 2.25 0.51 down from 2022 | 105 | 100% | $2,320 | ||
28Clinical Medicine Insights Arthritis and Musculoskeletal DisordersOASAGE Publishing · United Kingdom | 0.96Q2 | 2.28 1.05 down from 2022 | 41 | 100% | $4,150 | ||
29Osteoarthritis and Cartilage OpenOAElsevier BV · United Kingdom | 0.93Q2 | 2.37 0.40 up from 2022 | 226 | 100% | $1,610 | ||
30Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 0.91Q2 | 2.41 0.49 down from 2022 | 165 | 100% | $2,490 | ||
31The Journal of RheumatologyThe Journal of Rheumatology Publishing Company Limited · Canada | 0.89Q2 | 2.20 0.24 down from 2022 | 807 | 100% | — | ||
32Connective Tissue ResearchTaylor & Francis · United Kingdom | 0.87Q2 | 2.51 0.10 up from 2022 | 134 | 27% | — | ||
33LupusSAGE Publishing · United Kingdom | 0.86Q2 | 2.36 0.32 down from 2022 | 751 | 35% | $4,150 | ||
34Modern RheumatologyOxford University Press · United States | 0.85Q2 | 1.95 0.31 down from 2022 | 491 | 46% | $3,208 | ||
35Joint Bone SpineElsevier BV · France | 0.80Q3 | 2.33 0.27 down from 2022 | 496 | 47% | $3,020 | ||
36International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 0.78Q3 | 2.17 0.13 up from 2022 | 1,098 | 39% | $3,790 | ||
37Musculoskeletal CareWiley · United Kingdom | 0.76Q3 | 1.95 0.14 up from 2022 | 263 | 79% | $3,240 | ||
38International Journal of Rheumatic DiseasesWiley · Australia | 0.76Q3 | 2.42 0.09 down from 2022 | 647 | 56% | $3,700 | ||
39Rheumatology Advances in PracticeOAOxford University Press · United Kingdom | 0.67Q3 | 1.68 0.78 down from 2022 | 293 | 100% | $2,974 | ||
40Reumatologia/RheumatologyOATermedia Publishing House · Poland | 0.66Q3 | 1.75 0.39 down from 2022 | 204 | 100% | — | ||
41ReumatismoOAPAGEPress (Italy) · Italy | 0.64Q3 | 1.83 0.15 up from 2022 | 92 | 100% | — | ||
42Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 0.63Q3 | 1.86 0.33 up from 2022 | 303 | 38% | — | ||
43UrogynecologyLippincott Williams & Wilkins · United States | 0.57Q3 | 1.27 0.23 down from 2022 | 462 | 17% | — | ||
44Rheumatology and Immunology ResearchOADe Gruyter · Poland | 0.55Q3 | 1.50 0.55 up from 2022 | 77 | 100% | $0 listed | ||
45JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.51Q3 | 1.70 0.39 up from 2022 | 608 | 14% | — | ||
46Archives of RheumatologyOATürkiye | 0.50Q3 | 1.24 0.17 up from 2022 | 253 | 100% | — | ||
47European Journal of RheumatologyOAAVES Yayincilik · Türkiye | 0.49Q3 | 1.26 0.26 down from 2022 | 167 | 100% | — | ||
48Mediterranean Journal of RheumatologyOAGreece | 0.47Q3 | 1.17 0.01 down from 2022 | 175 | 100% | — | ||
49Case Reports in RheumatologyOAHindawi Publishing Corporation · United Kingdom | 0.46Q3 | 1.23 0.30 up from 2022 | 127 | 100% | $790 | ||
50Rheumatology & autoimmunityOAWiley · United Kingdom | 0.45Q3 | 1.19 0.69 up from 2022 | 48 | 100% | $3,000 |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
22 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 67
- Window papers (baseline)
- 67,501 +13.6% from indicator year 2020
- Median OJR
- 0.851 -13.7% from indicator year 2020
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.